Scinai Immunotherapeutics Ltd. (SCNI)
Nasdaq: SCNI · Biological Products, (No Diagnostic Substances) · Jerusalem, IL · filing with the SEC since 2014
Who runs Scinai Immunotherapeutics Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Reichman Amir
Chief Executive Officer. First filing Jan 2023, latest Jun 18, 2026, 0 filings in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
12 people on the record since 2023
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Reichman Amir | Chief Executive Officer | Jan 2023 | Jun 18, 2026 | none |
| Mark Elad | Chief Operating Officer | Jan 2023 | Mar 26, 2026 | none |
| Ben-Or Uri | Chief Financial Officer | Jan 2023 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Germain Mark | director | Jan 2023 | Jun 18, 2026 | none |
| Green Jay | director | Jan 2023 | Mar 18, 2026 | none |
| Margolin Yael | director | Jan 2023 | Mar 18, 2026 | none |
| Moed Samuel J | director | Jan 2023 | Mar 18, 2026 | none |
| Raviv Adi | director | Jan 2023 | Mar 18, 2026 | none |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.